It also contradicted a common belief that glucagon helped to promote type 2 diabetes (Tschp, Finan, Clemmensen
248,251,252 This mechanism is particularly evident in the use of GLP-1-based drugs, such as GLP-1RAs, in the treatment of T2DM
Source: Reference 1 Data on weight loss of GLP-1R agonists are being continuously refreshed along with the emergence of new iterations of the product
Similar content being viewed by others Introduction Class B G protein-coupled receptors (GPCRs), whose endogenous ligands are peptide hormones, are key mediators of normal human physiology and serve as valuable drug targets for many diseases including diabetes, metabolic syndrome, osteoporosis, migraine, depression, and anxiety 1
Although scientists do not yet fully understand the mechanisms underlying these wide-ranging actions, a clearer picture is beginning to emerge